Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: Stromal vascular fraction (SVF) can easily be obtained from a mini-lipoaspirate procedure of fat tissue and platelet rich plasma (PRP) can be obtained from peripheral blood. The SVF contains a mixture of cells including ADSCs and growth factors and has been depleted of the adipocyte (fat cell) population. We evaluated the safety and efficacy of administering SVF and PRP intra-discally into patients with degenerative disc disease. Methods: A total of 15 patients underwent a local tumescent liposuction procedure to remove approximately 60 ml of fat tissue. The fat was separated to isolate the SVF and the cells were delivered into the disc nucleus of patients with degenerative disc disease. The subjects were then monitored for adverse events, range of motion, visual analog scale (VAS), present pain intensity (PPI), Oswestry Disability Index (ODI), Beck Depression Inventory (BDI), Dallas Pain Questionnaire and Short Form (SF)-12 scores over a period of 6 months. Safety events were followed for 12 months. Results: No severe adverse events (SAEs) were reported during a 12 month follow up period with no incidences of infection. Patients demonstrated statistically significant improvements in several parameters including flexion, pain ratings, VAS, PPI, and short form questionnaires. In addition, both ODI and BDI data was trending positive and a majority of patients reported improvements in their Dallas Pain Questionnaire scores. Conclusions: Overall, patients were pleased with the treatment results. More importantly, the procedure demonstrated a strong safety profile with no severe adverse events or complications linked to the therapy. Trial registration NCT02097862. Name of registry: www.clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT02097862?term=bioheart&rank=6. Date of registration: March 25, 2014; Date of enrollment: March 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a 19.1% increase in lumbar range of motion ( P = 0.02) at 6months. [11]”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In patients with lumbar disc degenerative disease, SVF injection with PRP resulted in a 35.7% reduction in VAS pain scores ( P = 0.01)”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“In addition, ADSCs might play a role in the local inflammatory process [5, 6].”
BackgroundSecretion of angiogenic and antiapoptotic factors by human adipose stromal cells
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004) · Circulation · doi:10.1161/01.cir.0000121425.42966.f1 · Cited by 2,269 · cited 1×
“In addition, ADSCs might play a role in the local inflammatory process [5, 6].”
BackgroundCaplan, A. I., & Correa, D. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.008 · Cited by 1,682
Traktuev, D. O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., Johnstone, B. H., & March, K. L. (2008) · Circulation Research · doi:10.1161/circresaha.107.159475 · Cited by 839
Yield of human adipose-derived adult stem cells from liposuction aspirates
Aust, L., Devlin, B., Foster, S. J., Halvorsen, Y. D. C., Hicok, K., du Laney, T., Sen, A., Willingmyre, G. D., & Gimble, J. M. (2004) · Cytotherapy · doi:10.1080/14653240310004539 · Cited by 708 · cited 9×
“Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells, which can be isolated from various human adult tissues.”
BackgroundInfluentialIntervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study
Orozco, L., Soler, R., Morera, C., Alberca, M., Sánchez, A., & García-Sancho, J. (2011) · Transplantation · doi:10.1097/tp.0b013e3182298a15 · Cited by 514
Tuakli‐Wosornu, Y. A., Terry, A., Boachie‐Adjei, K., Harrison, J. R., Gribbin, C. K., LaSalle, E. E., Nguyen, J. T., Solomon, J. L., & Lutz, G. E. (2016) · PM&R · doi:10.1016/j.pmrj.2015.08.010 · Cited by 269
Adipose-Derived Mesenchymal Stem Cells: Biology and Potential Applications
Minteer, D., Marra, K. G., & Rubin, J. P. (2012) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2012_146 · Cited by 201 · cited 1×
“Stem cells derived from a patient’s own fat are referred to as adipose-derived stem cells [4].”
BackgroundPettine, K. A., Suzuki, R. K., Sand, T. T., & Murphy, M. (2015) · International Orthopaedics · doi:10.1007/s00264-015-2886-4 · Cited by 115 · cited 1×
“There was a 71% reduction in VAS pain scales and ODI improvements through 2 years [15].”
BackgroundJang, Y., Koh, Y. G., Choi, Y.-J., Kim, S., Yoon, D. S., Lee, M., & Lee, J. W. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9814-6 · Cited by 77 · cited 9×
“Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells, which can be isolated from various human adult tissues.”
BackgroundInfluential
Cited by
Cell-based strategies for IVD repair: clinical progress and translational obstacles
Binch, A. L. A., Fitzgerald, J. C., Growney, E. A., & Barry, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00568-w · Cited by 296
Wu, P. H., Kim, H. S., & Jang, I.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062135 · Cited by 266
Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration
Krut, Z., Pelled, G., Gazit, D., & Gazit, Z. (2021) · Cells · doi:10.3390/cells10092241 · Cited by 175
Sayed, D., Grider, J. S., Strand, N. H., Hagedorn, J. M., Falowski, S. M., Lam, C. M., Francio, V. T., Beall, D. P., Tomycz, N. D., Davanzo, J. R., et al. (2022) · Journal of Pain Research · doi:10.2147/jpr.s386879 · Cited by 170
Chu, D., Nguyen, T. T. P., Tien, N. L. B., Khoa, T. D., Bui, L. M., Thanh, V. V., Pham, A. G., Pham, V.-H., & Nga, V. T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070917 · Cited by 160
“SVF, non-insolated ASCs from adipose tissue, can also improve the outcome in degenerative disc disease with no adverse effects [103].”
Background
Metadata
- Authors
- Comella, K., Silbert, R., & Parlo, M.
- Affiliations
- U.S. Stem Cell (United States) (US)
- Corresponding author
- Comella, Kristin
- Venue
- Journal of Translational Medicine
- Published
- 2017-01-13
- Volume
- 15
- Issue
- 1
- Pages
- 108-108
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC5237154
- OpenAlex
- W2578546790
- Cited by
- 125
- References
- 16
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 9 · 2023: 7 · 2022: 14 · 2021: 19 · 2020: 13 · 2019: 18 · 2018: 12 · 2017: 8
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-05-22)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Spine and Intervertebral Disc Pathology
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- stromal vascular fraction, platelet-rich plasma, intervertebral disc degeneration, intradiscal injection, adipose-derived stem cells, tumescent liposuction, low back pain, treatment safety, range of motion, disability
- MeSH terms
- Adipose Tissue, Adult, Aged, Female, Humans, Intervertebral Disc, Male, Middle Aged, Surveys and Questionnaires, Treatment Outcome, Stromal Cells, Adipogenesis, Platelet-Rich Plasma, Intervertebral Disc Degeneration, Visual Analog Scale
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease. https://app.cochat.ai/papers/10.1186/s12967-016-1109-0
- The paper
- Comella, K., Silbert, R., & Parlo, M. (2017). Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease. Journal of Translational Medicine. https://doi.org/10.1186/s12967-016-1109-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.